303 related articles for article (PubMed ID: 28498810)
1. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies.
Yu M; Chen S; Hong W; Gu Y; Huang B; Lin Y; Zhou Y; Jin H; Deng Y; Tu L; Hou B; Jian Z
J Cancer Res Clin Oncol; 2019 Apr; 145(4):967-999. PubMed ID: 30825027
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
Zhang C; Xu J; Xue S; Ye J
Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
7. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
Deng Y; Zou J; Deng T; Liu J
Medicine (Baltimore); 2018 Nov; 97(48):e12961. PubMed ID: 30508885
[TBL] [Abstract][Full Text] [Related]
9. TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis.
Zhang Y; Cai P; Liang T; Wang L; Hu L
Oncotarget; 2017 May; 8(19):31705-31713. PubMed ID: 28423646
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
Poojary M; Jishnu PV; Kabekkodu SP
Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
[TBL] [Abstract][Full Text] [Related]
12. [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].
Jóźwiak P; Lipińska A
Postepy Hig Med Dosw (Online); 2012 Jan; 66():165-74. PubMed ID: 22470192
[TBL] [Abstract][Full Text] [Related]
13. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
[TBL] [Abstract][Full Text] [Related]
14. High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer.
Fang J; Qiao F; Tu J; Xu J; Ding F; Liu Y; Akuo BA; Hu J; Shao S
Oncotarget; 2017 Jul; 8(28):45918-45927. PubMed ID: 28507281
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
16. Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Tan Z; Yang C; Zhang X; Zheng P; Shen W
Oncotarget; 2017 Sep; 8(37):60954-60961. PubMed ID: 28977837
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer.
Fan Y; Yan T; Chai Y; Jiang Y; Zhu X
Clin Chim Acta; 2018 Jul; 482():224-230. PubMed ID: 28778381
[TBL] [Abstract][Full Text] [Related]
18. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
[TBL] [Abstract][Full Text] [Related]
19. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Shen YM; Arbman G; Olsson B; Sun XF
Int J Biol Markers; 2011; 26(3):166-72. PubMed ID: 21786248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
